Ligand validation:3VIB

CXS: 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID

CXS is a Ligand Of Interest in 3VIB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VIB_CXS_B_213	5%	19%	0.298	0.715	2.18	1.27	1	2	3	0	100%	1
3VIB_CXS_D_211	1%	20%	0.403	0.504	2.18	1.26	1	2	2	0	100%	1
3VIB_CXS_C_211	0%	20%	0.483	0.41	2.17	1.26	1	2	1	0	100%	1
3VIB_CXS_A_212	0%	20%	0.476	0.374	2.16	1.26	1	2	9	0	100%	1
8FW8_CXS_A_301	16%	21%	0.327	0.896	1.34	1.98	3	6	2	0	100%	1
9AUQ_CXS_B_202	100%	16%	0.03	0.993	2.34	1.36	2	2	0	0	100%	1
6GAL_CXS_M_604	100%	35%	0.043	0.993	1.04	1.52	1	2	0	0	100%	1
2QGQ_CXS_F_501	99%	54%	0.054	0.987	0.76	1.03	-	1	0	0	100%	1
3OBL_CXS_B_134	98%	19%	0.058	0.981	2.3	1.18	2	3	0	0	100%	1
1RZL_CXS_A_201	97%	29%	0.067	0.984	1.4	1.44	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.